New and Emerging Treatment Strategies for Gastrointestinal Diseases

Dear Colleagues,

Gastrointestinal homeostasis is orchestrated by complex regulatory mechanisms, including a protective epithelial barrier, a diverse microbiota and a highly regulated immune response controlled by different mucosal cell types. However, disruption of these mechanisms can lead to the development of acute and/or chronic pathological processes characterized by widely recognized problems, including gastroesophageal reflux, peptic ulcers, bile acid disorder, inflammatory bowel disease and others. Current treatment options for problems related to the gastrointestinal tract are limited and do not fully meet the needs of patients. In addition, prolonged use of some medications can have serious adverse effects. Therefore, the search for new treatment options is necessary.

Original papers and review articles are welcome for the Special Issue entitled “New and Emerging Treatment Strategies for Gastrointestinal Diseases”. Manuscripts must cover all aspects of the following:

• Advances and challenges in the development of new and novel treatment strategies for gastrointestinal diseases
• Extraction/isolation and identification of extracts or bioactive compounds for the treatment of gastrointestinal diseases
• Benefits and safety of new treatment strategies for gastrointestinal diseases

Dr. Daniele Maria-Ferreira
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• gastrointestinal diseases
• gastrointestinal homeostasis
• gastrointestinal injuries
• gastrointestinal disturbances
• dysbiosis
• bile acid
• inflammatory bowel diseases
• diarrhea